These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 25687773)

  • 21. Genome-wide association study identifies
    Chen J; Yu JT; Wojta K; Wang HF; Zetterberg H; Blennow K; Yokoyama JS; Weiner MW; Kramer JH; Rosen H; Miller BL; Coppola G; Boxer AL;
    Neurology; 2017 Feb; 88(7):669-676. PubMed ID: 28100725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. APOE, MAPT, and COMT and Parkinson's Disease Susceptibility and Cognitive Symptom Progression.
    Paul KC; Rausch R; Creek MM; Sinsheimer JS; Bronstein JM; Bordelon Y; Ritz B
    J Parkinsons Dis; 2016 Apr; 6(2):349-59. PubMed ID: 27061069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variants in GBA, SNCA, and MAPT influence Parkinson disease risk, age at onset, and progression.
    Davis AA; Andruska KM; Benitez BA; Racette BA; Perlmutter JS; Cruchaga C
    Neurobiol Aging; 2016 Jan; 37():209.e1-209.e7. PubMed ID: 26601739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study.
    Tobin JE; Latourelle JC; Lew MF; Klein C; Suchowersky O; Shill HA; Golbe LI; Mark MH; Growdon JH; Wooten GF; Racette BA; Perlmutter JS; Watts R; Guttman M; Baker KB; Goldwurm S; Pezzoli G; Singer C; Saint-Hilaire MH; Hendricks AE; Williamson S; Nagle MW; Wilk JB; Massood T; Laramie JM; DeStefano AL; Litvan I; Nicholson G; Corbett A; Isaacson S; Burn DJ; Chinnery PF; Pramstaller PP; Sherman S; Al-hinti J; Drasby E; Nance M; Moller AT; Ostergaard K; Roxburgh R; Snow B; Slevin JT; Cambi F; Gusella JF; Myers RH
    Neurology; 2008 Jul; 71(1):28-34. PubMed ID: 18509094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of tau gene polymorphism with age at onset of Parkinson's disease.
    Kobayashi H; Ujike H; Hasegawa J; Yamamoto M; Kanzaki A; Sora I
    Neurosci Lett; 2006 Sep; 405(3):202-6. PubMed ID: 16876320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Replication of GWAS associations for GAK and MAPT in Parkinson's disease.
    Rhodes SL; Sinsheimer JS; Bordelon Y; Bronstein JM; Ritz B
    Ann Hum Genet; 2011 Mar; 75(2):195-200. PubMed ID: 21058943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The apolipoprotein E epsilon 4 allele in Parkinson's disease with Alzheimer lesions.
    Egensperger R; Bancher C; Kösel S; Jellinger K; Mehraein P; Graeber MB
    Biochem Biophys Res Commun; 1996 Jul; 224(2):484-6. PubMed ID: 8702415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pinpointing novel risk loci for Lewy body dementia and the shared genetic etiology with Alzheimer's disease and Parkinson's disease: a large-scale multi-trait association analysis.
    Guo P; Gong W; Li Y; Liu L; Yan R; Wang Y; Zhang Y; Yuan Z
    BMC Med; 2022 Jun; 20(1):214. PubMed ID: 35729600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of risk factor variants of LRRK2, MAPT, SNCA and TCEANC2 genes in Hungarian sporadic Parkinson's disease patients.
    Boros FA; Török R; Vágvölgyi-Sümegi E; Pesei ZG; Klivényi P; Vécsei L
    Neurosci Lett; 2019 Jul; 706():140-145. PubMed ID: 31085292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) gene interactions with the apolipoprotein E epsilon4 allele as risk factors in Alzheimer's disease and in Parkinson's disease with coexisting Alzheimer pathology.
    Mattila KM; Rinne JO; Röyttä M; Laippala P; Pietilä T; Kalimo H; Koivula T; Frey H; Lehtimäki T
    J Med Genet; 2000 Oct; 37(10):766-70. PubMed ID: 11015454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease.
    Edwards TL; Scott WK; Almonte C; Burt A; Powell EH; Beecham GW; Wang L; Züchner S; Konidari I; Wang G; Singer C; Nahab F; Scott B; Stajich JM; Pericak-Vance M; Haines J; Vance JM; Martin ER
    Ann Hum Genet; 2010 Mar; 74(2):97-109. PubMed ID: 20070850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2.
    Pankratz N; Beecham GW; DeStefano AL; Dawson TM; Doheny KF; Factor SA; Hamza TH; Hung AY; Hyman BT; Ivinson AJ; Krainc D; Latourelle JC; Clark LN; Marder K; Martin ER; Mayeux R; Ross OA; Scherzer CR; Simon DK; Tanner C; Vance JM; Wszolek ZK; Zabetian CP; Myers RH; Payami H; Scott WK; Foroud T;
    Ann Neurol; 2012 Mar; 71(3):370-84. PubMed ID: 22451204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single-cell epigenomic analyses implicate candidate causal variants at inherited risk loci for Alzheimer's and Parkinson's diseases.
    Corces MR; Shcherbina A; Kundu S; Gloudemans MJ; Frésard L; Granja JM; Louie BH; Eulalio T; Shams S; Bagdatli ST; Mumbach MR; Liu B; Montine KS; Greenleaf WJ; Kundaje A; Montgomery SB; Chang HY; Montine TJ
    Nat Genet; 2020 Nov; 52(11):1158-1168. PubMed ID: 33106633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship between four GWAS-identified loci in Alzheimer's disease and the risk of Parkinson's disease, amyotrophic lateral sclerosis, and multiple system atrophy.
    Chen Y; Cao B; Chen X; Ou R; Wei Q; Zhao B; Wu Y; Yuan L; Shang HF
    Neurosci Lett; 2018 Nov; 686():205-210. PubMed ID: 30144538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of tau haplotype-tagging polymorphisms with Parkinson's disease in diverse ethnic Parkinson's disease cohorts.
    Fung HC; Xiromerisiou G; Gibbs JR; Wu YR; Eerola J; Gourbali V; Hellström O; Chen CM; Duckworth J; Papadimitriou A; Tienari PJ; Hadjigeorgiou GM; Hardy J; Singleton AB
    Neurodegener Dis; 2006; 3(6):327-33. PubMed ID: 17192721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MAPT rs17649553 T allele is associated with better verbal memory and higher small-world properties in Parkinson's disease.
    Chen Z; Wu B; Li G; Zhou L; Zhang L; Liu J
    Neurobiol Aging; 2023 Sep; 129():219-231. PubMed ID: 37413784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Haplotype-based association analysis of the MAPT locus in late onset Alzheimer's disease.
    Mukherjee O; Kauwe JS; Mayo K; Morris JC; Goate AM
    BMC Genet; 2007 Jan; 8():3. PubMed ID: 17266761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of genome-wide association studies of Alzheimer disease and of Parkinson disease to determine if these 2 diseases share a common genetic risk.
    Moskvina V; Harold D; Russo G; Vedernikov A; Sharma M; Saad M; Holmans P; Bras JM; Bettella F; Keller MF; Nicolaou N; Simón-Sánchez J; Gibbs JR; Schulte C; Durr A; Guerreiro R; Hernandez D; Brice A; Stefánsson H; Majamaa K; Gasser T; Heutink P; Wood N; Martinez M; Singleton AB; Nalls MA; Hardy J; Owen MJ; O'Donovan MC; Williams J; Morris HR; Williams NM;
    JAMA Neurol; 2013 Oct; 70(10):1268-76. PubMed ID: 23921447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Alzheimer's disease GWAS loci with MRI markers of brain aging.
    Chauhan G; Adams HHH; Bis JC; Weinstein G; Yu L; Töglhofer AM; Smith AV; van der Lee SJ; Gottesman RF; Thomson R; Wang J; Yang Q; Niessen WJ; Lopez OL; Becker JT; Phan TG; Beare RJ; Arfanakis K; Fleischman D; Vernooij MW; Mazoyer B; Schmidt H; Srikanth V; Knopman DS; Jack CR; Amouyel P; Hofman A; DeCarli C; Tzourio C; van Duijn CM; Bennett DA; Schmidt R; Longstreth WT; Mosley TH; Fornage M; Launer LJ; Seshadri S; Ikram MA; Debette S
    Neurobiol Aging; 2015 Apr; 36(4):1765.e7-1765.e16. PubMed ID: 25670335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Weighted Genetic Risk Score Based on Four APOE-Independent Alzheimer's Disease Risk Loci May Supplement APOE E4 for Better Disease Prediction.
    Zhang C; Hu R; Zhang G; Zhe Y; Hu B; He J; Wang Z; Qi X
    J Mol Neurosci; 2019 Nov; 69(3):433-443. PubMed ID: 31346968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.